Search company, investor...

Nucaps Nanotechnology

nucapsnanotechnology.com

Founded Year

2016

Stage

Seed VC | Alive

Total Raised

$570K

Last Raised

$430K | 3 yrs ago

About Nucaps Nanotechnology

Nucaps offers original capsules as well as a new and versatile encapsulation technology applicable to food, cosmetic, nutraceutical and pharmaceutical purposes. These microcapsules use food proteins (GRAS grade) which are capable to load and encapsulate a wide variety of additives, drugs and biological active compounds.

Headquarters Location

Polígono Mocholi, Vivero CEIN Nave B8

Navarra, 31110,

Spain

Nucaps Nanotechnology's Product Videos

IMG 0883.jpg

Compete with Nucaps Nanotechnology?

Ensure that your company and products are accurately represented on our platform.

Nucaps Nanotechnology's Products & Differentiators

    NUCLA

    Nucla, a natural product that allows the reduction of salt in food maintaining nutritional and organoleptic properties and food experience as well as a clean-label. With our technology we use a protein to get a controlled release in mouth of the salt, creating an experience of more intense salty flavour with a much lower quantity of sodium... a reduction over the 25% needed to claim "low in salt", but it could be reduced even more.

Expert Collections containing Nucaps Nanotechnology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nucaps Nanotechnology is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Nucaps Nanotechnology News

Nucaps Nanotechnology cierra una ampliación de capital de 400.000 euros

Mar 31, 2020

Nucaps Nanotechnology , una startup de origen navarro, ha recibido una inyección de capital de 400.000€ a través del Fondo UN I+D+I Tech Transfer, gestionado por la gestora de capital riesgo Clave , de CNTA y de la Universidad de Navarra. Esta dotación económica aportará a la startup, no solo liquidez, sino también la opción de incorporar a su cartera nuevas tecnologías desarrolladas por los investigadores de la Universidad de Navarra y de CNTA con el objetivo de impulsar la industrialización de las nanocápsulas y atender así las demandas del mercado. En concreto, los fondos aportados se destinarán a dotar a la sociedad de medios productivos para encapsulación de bioactivos y probióticos y continuar con la expansión de la compañía. También permitirá continuar reforzando el equipo técnico de Nucaps con la contratación de personal cualificado. La principal innovación de Nucaps reside en que permite introducir bioactivos y probióticos en nanocápsulas fabricadas únicamente con proteínas alimentarias de la leche, el maíz o la soja para la administración oral y la liberación controlada de fármacos o microorganismos con fines nutricionales, cosméticos y farmacéuticos. La tecnología de Nucaps ha demostrado su potencial disruptivo en nutrición y salud como lo demuestran los diversos reconocimientos internacionales recibidos en 2019 (FI Innovations Awards 2019: “Future of Nutrition”; Smart Agrifood Summit 2019: “Best technological solution”; Premio Ingenia Food4Life 2019; Premios Expansion 2019: 2º premio Alimentación y Agrotech, entre otros), su participación en proyectos de I+D cofinanciados por el Gobierno de Navarra y la Unión Europea y la firma de contratos y acuerdos de colaboración con empresas nacionales e internacionales. Clave se une con esta inversión a los actuales socios de la startup: Universidad de Navarra, CNTA e Idifarma, incorporándose a su Consejo de Administración donde aportará, según Mariano Oto, director general de Nucaps, "su amplia experiencia en el desarrollo de negocio de empresas tecnológicas innovadoras". Oto ha señalado que “esta ampliación de capital supondrá ampliar y escalar la compañía para acceder a nuevos mercados, retos y oportunidades, ya que el sector ha validado el interés de su tecnología y su potencial para mejorar la salud de las personas”. Por su parte, Santiago Lozano, director de fondos de Clave, ha destacado que "Nucaps ha alcanzado un reconocimiento en el mercado como empresa de referencia en la encapsulación con proteínas naturales con la ejecución de sus primeros proyectos, lo que la posicionan en una buena situación para abordar el siguiente reto empresarial de la mano de sus socios y partners". Si te ha interesado esta información, te recomendamos ...

Nucaps Nanotechnology Frequently Asked Questions (FAQ)

  • When was Nucaps Nanotechnology founded?

    Nucaps Nanotechnology was founded in 2016.

  • Where is Nucaps Nanotechnology's headquarters?

    Nucaps Nanotechnology's headquarters is located at Polígono Mocholi, Vivero CEIN, Navarra.

  • What is Nucaps Nanotechnology's latest funding round?

    Nucaps Nanotechnology's latest funding round is Seed VC.

  • How much did Nucaps Nanotechnology raise?

    Nucaps Nanotechnology raised a total of $570K.

  • Who are the investors of Nucaps Nanotechnology?

    Investors of Nucaps Nanotechnology include Clave, University of Navarra, Startup Europe Smart Agrifood Summit, EIT Food and Universitat Politecnica de Valencia.

  • Who are Nucaps Nanotechnology's competitors?

    Competitors of Nucaps Nanotechnology include DSM and 5 more.

  • What products does Nucaps Nanotechnology offer?

    Nucaps Nanotechnology's products include NUCLA and 3 more.

Compare Nucaps Nanotechnology to Competitors

PredictHQ Logo
PredictHQ

PredictHQ allows major organizations in the airline, accommodation, retail, and transport sectors to accurately anticipate fluctuations in demand for their products, services, and on their staff. By leveraging intelligence on upcoming concerts, sporting events, conferences, school holidays, severe weather and more, the system lets companies understand people movement and its impact on commerce via one global events API.

CloudHedge Logo
CloudHedge

CloudHedge uses AI to analyze existing applications, and automatically recommend and transform monolith applications to cloud-native. The company not only supports the Lift-Shift model but can also Re-Factor and containerize automatically.

Traent Logo
Traent

Traent is an integrated blockchain collaboration platform that facilitates and secures interactions between people, companies and organizations.

MyHealthTeams Logo
MyHealthTeams

MyHealthTeams creates patient social networks, making it easy for people living with a chronic health condition to connect. Each social network is an active, monitored, password-protected community where diagnosed patients can safely discuss their experiences, challenges, and successes, and find objective, medically reviewed educational content.

Fano Labs Logo
Fano Labs

Fano Labs specializes in developing speech recognition, speaker verification, and natural language processing (NLP) technologies for multilingual environments. Its offers speech analytics, AI transcription, AI voice bot, AI outbound calls, and more for bank and financial services, telecom, insurance, utilities, aviation, retail, public sector, government, and other sectors. The company was founded in 2015 and is based in Hong Kong.

Miovision Logo
Miovision

Miovision helps build smart cities by transforming traffic management. Its signal planning and operations help improve the transportation experience for drivers, cyclists, and pedestrians. The company was founded in 2005 and is based in Kitchener, Ontario.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.